• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥沙利铂长循环脂质体的表征和药代动力学评价。

Characterization and Pharmacokinetic Evaluation of Oxaliplatin Long-Circulating Liposomes.

机构信息

State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.

Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.

出版信息

Biomed Res Int. 2021 Apr 20;2021:5949804. doi: 10.1155/2021/5949804. eCollection 2021.

DOI:10.1155/2021/5949804
PMID:33987441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8079196/
Abstract

The clinical efficacy of Oxaliplatin (L-OHP) is potentially limited by dose-dependent neurotoxicity and high partitioning to erythrocytes . Long-circulating liposomes could improve the pharmacokinetic profile of L-OHP and thus enhance its therapeutic efficacy and reduce its toxicity. The purpose of this study was to prepare L-OHP long-circulating liposomes (L-OHP PEG lip) by reverse-phase evaporation method (REV) and investigate their pharmacokinetic behavior based on total platinum in rat plasma using atomic absorption spectrometry (AAS). A simple and a sensitive AAS method was developed and validated to determine the total platinum originated from L-OHP liposomes in plasma. Furthermore, long-circulating liposomes were fully characterized and showed great stability when stored at 4°C for one month. The results showed that the total platinum in plasma of L-OHP long-circulating liposomes displayed a biexponential pharmacokinetic profile with five folds higher bioavailability and longer distribution half-life compared to L-OHP solution. Thus, long-circulating liposomes prolonged L-OHP circulation time and may present a potential candidate for its tumor delivery. Conclusively, the developed AAS method could serve as a reference to investigate the pharmacokinetic behavior of total platinum in biological matrices for other L-OHP delivery systems.

摘要

奥沙利铂(L-OHP)的临床疗效可能受到剂量依赖性神经毒性和高红细胞分配的限制。长循环脂质体可以改善 L-OHP 的药代动力学特征,从而提高其治疗效果并降低其毒性。本研究旨在通过反相蒸发法(REV)制备奥沙利铂长循环脂质体(L-OHP PEG 脂质体),并基于原子吸收光谱法(AAS)在大鼠血浆中用总铂来研究其药代动力学行为。建立并验证了一种简单灵敏的 AAS 方法,用于测定来自血浆中 L-OHP 脂质体的总铂。此外,对长循环脂质体进行了充分的表征,并且在 4°C 下储存一个月时表现出很好的稳定性。结果表明,与 L-OHP 溶液相比,L-OHP 长循环脂质体在血浆中的总铂呈现双指数药代动力学特征,生物利用度提高了五倍,分布半衰期延长。因此,长循环脂质体延长了 L-OHP 的循环时间,可能成为其肿瘤递药的潜在候选物。总之,所开发的 AAS 方法可以作为研究其他 L-OHP 递药系统在生物基质中总铂药代动力学行为的参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c975/8079196/fcd85edeb2da/BMRI2021-5949804.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c975/8079196/32633d412cdb/BMRI2021-5949804.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c975/8079196/663a2d37ec51/BMRI2021-5949804.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c975/8079196/add1a8711803/BMRI2021-5949804.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c975/8079196/5033d8d3936f/BMRI2021-5949804.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c975/8079196/ad32a2e7c35b/BMRI2021-5949804.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c975/8079196/fcd85edeb2da/BMRI2021-5949804.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c975/8079196/32633d412cdb/BMRI2021-5949804.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c975/8079196/663a2d37ec51/BMRI2021-5949804.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c975/8079196/add1a8711803/BMRI2021-5949804.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c975/8079196/5033d8d3936f/BMRI2021-5949804.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c975/8079196/ad32a2e7c35b/BMRI2021-5949804.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c975/8079196/fcd85edeb2da/BMRI2021-5949804.006.jpg

相似文献

1
Characterization and Pharmacokinetic Evaluation of Oxaliplatin Long-Circulating Liposomes.奥沙利铂长循环脂质体的表征和药代动力学评价。
Biomed Res Int. 2021 Apr 20;2021:5949804. doi: 10.1155/2021/5949804. eCollection 2021.
2
Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin.长循环热敏脂质体用于奥沙利铂的靶向药物递送。
Int J Nanomedicine. 2020 Sep 11;15:6721-6734. doi: 10.2147/IJN.S250773. eCollection 2020.
3
Intratumoral Visualization of Oxaliplatin within a Liposomal Formulation Using X-ray Fluorescence Spectrometry.X 射线荧光光谱法用于脂质体制剂中奥沙利铂的瘤内可视化。
Mol Pharm. 2018 Feb 5;15(2):403-409. doi: 10.1021/acs.molpharmaceut.7b00762. Epub 2018 Jan 16.
4
[Elucidation for Intratumor Localization of a DDS-based Anticancer Drug and Enhancement of Its Therapeutic Effects via Improvement of the Tumor Microenvironment].[基于药物递送系统的抗癌药物肿瘤内定位及通过改善肿瘤微环境增强其治疗效果的阐释]
Yakugaku Zasshi. 2021;141(11):1241-1245. doi: 10.1248/yakushi.21-00148.
5
Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome.转铁蛋白-聚乙二醇脂质体包裹的奥沙利铂具有有效的抗肿瘤活性。
Int J Pharm. 2008 Jan 4;346(1-2):143-50. doi: 10.1016/j.ijpharm.2007.06.010. Epub 2007 Jun 16.
6
Liposomalization of oxaliplatin induces skin accumulation of it, but negligible skin toxicity.奥沙利铂的脂质体化诱导其在皮肤中的蓄积,但皮肤毒性可忽略不计。
Toxicol Appl Pharmacol. 2017 Dec 15;337:76-84. doi: 10.1016/j.taap.2017.10.006. Epub 2017 Oct 17.
7
Oxaliplatin long-circulating liposomes improved therapeutic index of colorectal carcinoma.奥沙利铂长循环脂质体提高结直肠癌的治疗指数。
BMC Biotechnol. 2011 Mar 15;11:21. doi: 10.1186/1472-6750-11-21.
8
Pharmacokinetic and toxicodynamic evaluation of oxaliplatin-induced neuropathy and hematological toxicity in rats.奥沙利铂诱导的周围神经毒性和血液学毒性的药代动力学和毒代动力学评价。
Cancer Chemother Pharmacol. 2018 Jan;81(1):155-161. doi: 10.1007/s00280-017-3485-4. Epub 2017 Nov 21.
9
Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of oxaliplatin for hematological toxicity in rats.基于机制的奥沙利铂对大鼠血液学毒性的药代动力学-药效学(PK-PD)建模与模拟
Xenobiotica. 2020 Feb;50(2):223-230. doi: 10.1080/00498254.2019.1601790. Epub 2019 Apr 25.
10
Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: synergy or antagonism?在结直肠肿瘤模型中,采用 S-1 节拍剂量给药联合含奥沙利铂的聚乙二醇涂层阳离子脂质体的联合治疗:协同作用还是拮抗作用?
Int J Pharm. 2012 Apr 15;426(1-2):263-270. doi: 10.1016/j.ijpharm.2012.01.046. Epub 2012 Jan 30.

引用本文的文献

1
Mechanism of Action of Dihydroquercetin in the Prevention and Therapy of Experimental Liver Injury.二氢槲皮素防治实验性肝损伤的作用机制。
Molecules. 2024 Jul 27;29(15):3537. doi: 10.3390/molecules29153537.
2
Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy.纳米蛋白酶体靶向嵌合体(Nano-PROTACs)在癌症治疗中的应用。
Int J Nanomedicine. 2024 Jun 12;19:5739-5761. doi: 10.2147/IJN.S448684. eCollection 2024.
3
Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy.

本文引用的文献

1
Systemic Evaluation on the Pharmacokinetics of Platinum-Based Anticancer Drugs From Animal to Cell Level: Based on Total Platinum and Intact Drugs.从动物到细胞水平对铂类抗癌药物药代动力学的系统评价:基于总铂和完整药物
Front Pharmacol. 2020 Jan 8;10:1485. doi: 10.3389/fphar.2019.01485. eCollection 2019.
2
Rechallenge of oxaliplatin-containing regimens in the third- or later-line therapy for patients with heavily treated metastatic colorectal cancer.含奥沙利铂方案在接受过多次治疗的转移性结直肠癌患者三线及后续治疗中的再挑战。
Onco Targets Ther. 2018 May 1;11:2467-2473. doi: 10.2147/OTT.S154220. eCollection 2018.
3
用于奥沙利铂癌症治疗的位点特异性递送的纳米结构:协同癌症治疗中的多功能纳米平台。
Transl Oncol. 2024 Jan;39:101838. doi: 10.1016/j.tranon.2023.101838. Epub 2023 Nov 27.
4
A small-scale, exploratory real-world study of nab-paclitaxel combined with oxaliplatin and tegafur in the perioperative treatment of advanced gastric cancer: a study protocol for a real-world clinical trial.一项关于纳米白蛋白结合型紫杉醇联合奥沙利铂和替加氟用于晚期胃癌围手术期治疗的小规模探索性真实世界研究:一项真实世界临床试验的研究方案
J Gastrointest Oncol. 2023 Apr 29;14(2):1131-1140. doi: 10.21037/jgo-23-131. Epub 2023 Apr 27.
5
The Effect of Liposomal Diallyl Disulfide and Oxaliplatin on Proliferation of Colorectal Cancer Cells: In Vitro and In Silico Analysis.脂质体二烯丙基二硫化物与奥沙利铂对结肠癌细胞增殖的影响:体外与计算机模拟分析
Pharmaceutics. 2022 Jan 20;14(2):236. doi: 10.3390/pharmaceutics14020236.
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells.
顺铂脂质体与6-氨基烟酰胺联合使用以克服卵巢癌细胞的耐药性。
Oncotarget. 2018 Mar 30;9(24):16847-16860. doi: 10.18632/oncotarget.24708.
4
Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule.胆固醇调节脂质体膜的流动性和对亲水分子的通透性。
Food Chem Toxicol. 2018 Mar;113:40-48. doi: 10.1016/j.fct.2018.01.017. Epub 2018 Jan 12.
5
Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer.载过氧化氢酶的顺铂前药构建脂质体克服肿瘤乏氧用于增强癌症的放化疗
Biomaterials. 2017 Sep;138:13-21. doi: 10.1016/j.biomaterials.2017.05.025. Epub 2017 May 18.
6
IN VITRO RELEASE KINETICS MODEL FITTING OF LIPOSOMES: AN INSIGHT.脂质体的体外释放动力学模型拟合:深入剖析
Chem Phys Lipids. 2016 Oct 29. doi: 10.1016/j.chemphyslip.2016.10.005.
7
Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy.奥沙利铂和伊立替康共载脂质体的研制及其在增强结直肠癌治疗中的评价。
J Control Release. 2016 Sep 28;238:10-21. doi: 10.1016/j.jconrel.2016.07.022. Epub 2016 Jul 16.
8
Preparation and Evaluation of Oxaliplatin Thermosensitive Liposomes with Rapid Release and High Stability.具有快速释放和高稳定性的奥沙利铂热敏脂质体的制备与评价
PLoS One. 2016 Jul 14;11(7):e0158517. doi: 10.1371/journal.pone.0158517. eCollection 2016.
9
Optimizing the therapeutic efficacy of cisplatin PEGylated liposomes via incorporation of different DPPG ratios: In vitro and in vivo studies.通过掺入不同的 DPPG 比例优化顺铂聚乙二醇脂质体的治疗效果:体外和体内研究。
Colloids Surf B Biointerfaces. 2015 Dec 1;136:885-91. doi: 10.1016/j.colsurfb.2015.10.046. Epub 2015 Oct 31.
10
Tolerability of hypertonic injectables.高渗注射液的耐受性。
Int J Pharm. 2015 Jul 25;490(1-2):308-15. doi: 10.1016/j.ijpharm.2015.05.069. Epub 2015 May 29.